Literature DB >> 34315980

Mapping each pre-existing condition's association to short-term and long-term COVID-19 complications.

A J Venkatakrishnan1, Colin Pawlowski1, David Zemmour1, Travis Hughes1, Akash Anand2, Gabriela Berner1, Nikhil Kayal1, Arjun Puranik1, Ian Conrad1, Sairam Bade2, Rakesh Barve2, Purushottam Sinha2, John C O'Horo3, Andrew D Badley3, John Halamka3, Venky Soundararajan4.   

Abstract

Understanding the relationships between pre-existing conditions and complications of COVID-19 infection is critical to identifying which patients will develop severe disease. Here, we leverage ~1.1 million clinical notes from 1803 hospitalized COVID-19 patients and deep neural network models to characterize associations between 21 pre-existing conditions and the development of 20 complications (e.g. respiratory, cardiovascular, renal, and hematologic) of COVID-19 infection throughout the course of infection (i.e. 0-30 days, 31-60 days, and 61-90 days). Pleural effusion was the most frequent complication of early COVID-19 infection (89/1803 patients, 4.9%) followed by cardiac arrhythmia (45/1803 patients, 2.5%). Notably, hypertension was the most significant risk factor associated with 10 different complications including acute respiratory distress syndrome, cardiac arrhythmia, and anemia. The onset of new complications after 30 days is rare and most commonly involves pleural effusion (31-60 days: 11 patients, 61-90 days: 9 patients). Lastly, comparing the rates of complications with a propensity-matched COVID-negative hospitalized population confirmed the importance of hypertension as a risk factor for early-onset complications. Overall, the associations between pre-COVID conditions and COVID-associated complications presented here may form the basis for the development of risk assessment scores to guide clinical care pathways.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34315980     DOI: 10.1038/s41746-021-00484-7

Source DB:  PubMed          Journal:  NPJ Digit Med        ISSN: 2398-6352


  7 in total

1.  SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes.

Authors:  Colin Pawlowski; Eli Silvert; John C O'Horo; Patrick J Lenehan; Doug Challener; Esteban Gnass; Karthik Murugadoss; Jason Ross; Leigh Speicher; Holly Geyer; A J Venkatakrishnan; Andrew D Badley; Venky Soundararajan
Journal:  PNAS Nexus       Date:  2022-07-04

2.  The Role of Acupuncture for Long COVID: Mechanisms and Models.

Authors:  James E Williams; Jacques Moramarco
Journal:  Med Acupunct       Date:  2022-06-16

3.  Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients.

Authors:  Fadhel A Alomar; Marai N Alshakhs; Salah Abohelaika; Hassan M Almarzouk; Mohammed Almualim; Amein K Al-Ali; Fahad Al-Muhanna; Mohammed F Alomar; Mousa J Alhaddad; Mohammed S Almulaify; Faisal S Alessa; Ahmed S Alsalman; Ahmed Alaswad; Sean R Bidasee; Hassan A Alsaad; Rudaynah A Alali; Mona H AlSheikh; Mohammed S Akhtar; Mohammed Al Mohaini; Abdulkhaliq J Alsalman; Hussain Alturaifi; Keshore R Bidasee
Journal:  Sci Rep       Date:  2022-06-09       Impact factor: 4.996

4.  When Do We Need Massive Computations to Perform Detailed COVID-19 Simulations?

Authors:  Christopher B Lutz; Philippe J Giabbanelli
Journal:  Adv Theory Simul       Date:  2021-11-23

5.  Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records.

Authors:  Michiel J M Niesen; Colin Pawlowski; John C O'Horo; Doug W Challener; Eli Silvert; Greg Donadio; Patrick J Lenehan; Abinash Virk; Melanie D Swift; Leigh L Speicher; Joel E Gordon; Holly L Geyer; John D Halamka; A J Venkatakrishnan; Venky Soundararajan; Andrew D Badley
Journal:  JAMA Netw Open       Date:  2022-04-01

6.  Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations.

Authors:  Andrea Favalli; Ennio Giulio Favalli; Andrea Gobbini; Elena Zagato; Mauro Bombaci; Gabriella Maioli; Elisa Pesce; Lorena Donnici; Paola Gruarin; Martina Biggioggero; Serena Curti; Lara Manganaro; Edoardo Marchisio; Valeria Bevilacqua; Martina Martinovic; Tanya Fabbris; Maria Lucia Sarnicola; Mariacristina Crosti; Laura Marongiu; Francesca Granucci; Samuele Notarbartolo; Alessandra Bandera; Andrea Gori; Raffaele De Francesco; Sergio Abrignani; Roberto Caporali; Renata Grifantini
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

Review 7.  Parks and the Pandemic: A Scoping Review of Research on Green Infrastructure Use and Health Outcomes during COVID-19.

Authors:  Megan Heckert; Amanda Bristowe
Journal:  Int J Environ Res Public Health       Date:  2021-12-11       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.